2268-2269 / 2437
PROFILE trial 1014
(crizotinib vs chemotherapy)
intracranial progression free survival of pts with treated BM
Brain metastases in patients with ALK-positive NSCLC
BM - brain metastases
Solomon
et al 2016, J Clin Oncol; 34 (24), 2858-65
Crizotinib
Chemotherapy